CN Patent

CN1261794A — 增溶的舍曲林组合物

Assigned to Pfizer Products Inc · Expires 2000-08-02 · 26y expired

What this patent protects

本发明涉及含有舍曲林和增溶剂的组合物,其中,增溶剂用于提高舍曲林在含氯离子水性使用环境中的溶解性。

USPTO Abstract

本发明涉及含有舍曲林和增溶剂的组合物,其中,增溶剂用于提高舍曲林在含氯离子水性使用环境中的溶解性。

Drugs covered by this patent

lenvatinib-mesylate (LENVATINIB MESYLATE)

Patent Metadata

Patent number: CN1261794A
Jurisdiction: CN
Classification: —
Expires: 2000-08-02
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Products Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.